| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9328387 | Gynecologic Oncology | 2005 | 4 Pages |
Abstract
A review of the literature indicates a potential role for MAID chemotherapy in the treatment of ovarian angiosarcomas. Detection of Stage I disease appears to confer a better prognosis regardless of the utilization of adjuvant chemotherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Cherie D. Quesenberry, Cuizhen Li, Annette H. Chen, Susan L. Zweizig, Harrison G. III,